We observed a raw difference in secondary bacteremia that did not reach statistical significance that aligns with previous observations 41 , 42 .
← all excerpts
Benefit and risk associated with interleukin-6 receptor inhibitor administration during severe COVID-19: a retrospective multicentric study.
1
—
—